(Q48662294)

14 February 2018

title

Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. (English)

1 reference

14 February 2018

author name string

Keiko Tanaka

1

1 reference

14 February 2018

Tatsuo Akechi

2

1 reference

14 February 2018

Toru Okuyama

3

1 reference

14 February 2018

Yutaka Nishiwaki

4

1 reference

14 February 2018

Yosuke Uchitomi

5

1 reference

14 February 2018

publication date

1 May 2002

1 reference

14 February 2018

Journal of Pain and Symptom Management

published in

1 reference

14 February 2018

volume

23

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

417-423

1 reference

14 February 2018

Estimates of the worldwide mortality from 25 cancers in 1990.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Are increasing 5-year survival rates evidence of success against cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Symptoms in adults with lung cancer. A systematic research review

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

The interaction of age, symptoms, and survival status on physical and mental health of patients with cancer and their families.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

The predictive power of diagnostic tests and the effect of prevalence of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

The prevalence of psychiatric disorders among cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

Psychiatric morbidity in terminally ill cancer patients. A prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900376-7

7 January 2021

10.1016/S0885-3924(02)00376-7

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018